The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,213
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
McTaggart, F., Buckett, L., Davidson, R., Holdgate, G., McCormick, A., Schneck, D., Smith, G., & Warwick, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01454-0 · Cited by 413
Neuvonen, P. J., Kantola, T., & Kivistö, K. T. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90165-5 · Cited by 406
Human Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters
Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., & Du, B. N. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15082-9 · Cited by 402
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
Prueksaritanont, T., Subramanian, R., Fang, X., Ma, B., Qiu, Y., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.505 · Cited by 344
Self-citationIn Vitro Glucuronidation Using Human Liver Microsomes and The Pore-Forming Peptide Alamethicin
Fisher, M. B., Campanale, K., Ackermann, B. L., VandenBranden, M., & Wrighton, S. A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15100-8 · Cited by 343
Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & La Du, B. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004543200 · Cited by 338
Kantola, T., Kivistö, K. T., & Neuvonen, P. J. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90151-5 · Cited by 286
Tandem mass spectrometry: dissociation of ions by collisional activation
Shukla, A. K., & Futrell, J. H. (2000) · Journal of Mass Spectrometry · doi:10.1002/1096-9888(200009)35:9<1133::aid-jms42>3.0.co;2-x · Cited by 279
(1997) · PubMed · Cited by 271
Plasma concentrations of active simvastatin acid are increased by gemfibrozil
Backman, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108507 · Cited by 264
Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
Vickers, S., Duncan, C. A., Chen, I. W., Rosegay, A., & Duggan, D. E. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07595-6 · Cited by 246
Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid
Neuvonen, P. J., & Jalava, K.-M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90167-8 · Cited by 238
Jacobsen, W., Kuhn, B., Soldner, A., Kirchner, G., Sewing, K.-F., Kollman, P. A., Benet, L. Z., & Christians, U. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15086-6 · Cited by 236
Biotransformation of lovastatin
Wang, R. W., Kari, P. H., Lu, A. Y. H., Thomas, P. E., Guengerich, F. P., & Vyas, K. P. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90551-s · Cited by 196
Current and future treatment of hyperlipidemia: the role of statins
Farnier, M., & Davignon, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00423-8 · Cited by 193
Kyrklund, C., Backman, J. T., Kivistö, K. T., Neuvonen, M., Laitila, J., & Neuvonen, P. J. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115542 · Cited by 191
(1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00010-1 · Cited by 179
Drug Glucuronidation in Clinical Psychopharmacology
Liston, H. L., Markowitz, J. S., & DeVane, C. L. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00008 · Cited by 177
Igel, M., Sudhop, T., & von Bergmann, K. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100329 · Cited by 169
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.
Wen, X., Wang, J. S., Backman, J. T., Kivistö, K. T., & Neuvonen, P. J. (2001) · PubMed · Cited by 139
Clinical Pharmacokinetics of Cerivastatin
ck, W. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00002 · Cited by 135
Trapnell, C. B., Klecker, R. W., Jamis‐Dow, C., & Collins, J. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1592 · Cited by 113
Learning from the cerivastatin experience
Farmer, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06489-3 · Cited by 105
Prueksaritanont, T., Ma, B., Tang, C., Meng, Y., Assang, C., Lü, P., Reider, P. J., Lin, J. H., & Baillie, T. A. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00903.x · Cited by 102
Self-citationROGERS, J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.a101208 · Cited by 84
Boberg, M., Angerbauer, R., Fey, P., Kanhai, W. K., Karl, W., Kern, A., Ploschke, J., & Radtke, M. (1997) · PubMed · Cited by 77
Murdock, D. K., Murdock, A. K., Murdock, R., Olson, K. J., Frane, A. M., Kersten, M., Joyce, D. M., & Gantner, S. E. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70261-9 · Cited by 75
Drug Interactions with Antiviral Drugs
Taburet, A., & Singlas, E. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00005 · Cited by 69
Role of fibrates in the management of hypertriglyceridemia
Rader, D. J., & Haffner, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00270-2 · Cited by 46
Biotransformation of cerivastatin in mice, rats, and dogs in vivo.
Boberg, M., Angerbauer, R., Kanhai, W. K., Karl, W., Kern, A., Radtke, M., & Steinke, W. (1998) · PubMed · Cited by 45
Okerholm, R. A., Keeley, F. J., Peterson, F. E., & Glazko, A. J. (1976) · Proceedings of the Royal Society of Medicine · doi:10.1177/00359157760690s204 · Cited by 44
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Metabolic disposition of simvastatin in patients with T-tube drainage.
Cheng, H., Schwartz, M. S., Vickers, S., Gilbert, J. D., Amin, R. D., Depuy, B., Liu, L., Rogers, J. D., Pond, S. M., & Duncan, C. A. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08287-x · Cited by 38
Self-citationHamberger, C., Barré, J., Zini, R., Taiclet, A., Houin, G., & Tillement, J. P. (1986) · PubMed · Cited by 23
Cited by
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000794 · Cited by 928
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
Graham, D. J. (2004) · JAMA · doi:10.1001/jama.292.21.2585 · Cited by 875
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
NEUVONEN, P., NIEMI, M., & BACKMAN, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.003 · Cited by 859
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
Metadata
- Authors
- Prueksaritanont, T., Zhao, J. J., Ma, B., Roadcap, B. A., Tang, C., Qiu, Y., Liu, L., Lin, J. H., Pearson, P. G., & Baillie, T. A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 301
- Issue
- 3
- Pages
- 1042-1051
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2150797190
- Cited by
- 287
- References
- 36
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.